介质干细胞衍生的细胞外囊泡的治疗潜力:专注于炎症性肠病
Laura Clua-Ferré1, Roger Suau1, Irene Vañó-Segarra2
1Germans Trias i Pujol Research Institute IGTP, Inflammatory Bowel Diseases, Badalona, Spain.
Clinical and translational medicine
|November 3, 2024
概括
介酶干细胞衍生的细胞外囊泡 (MSC-EVs) 显示出治疗炎症性肠病 (IBD) 的前景. 这些无细胞疗法通过提供治疗性microRNAs来减少炎症并促进肠道愈合.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 介细胞干细胞衍生的细胞外囊泡 (MSC-EVs) 是关键的细胞间通信器.
- MSC-EVs模仿父细胞功能,提供免疫调节,促再生,抗亡和抗纤维作用.
- MSC-EVs为炎症性肠病 (IBD) 提供了一个无细胞的治疗选择,克服了细胞治疗的局限性.
研究的目的:
- 综合审查MSC-EVs在IBD中的治疗疗效.
- 检查MSC-EV的作用机制及其对治疗结果的影响.
- 讨论MSC-EV在传统疗法,隔离方法和表征方面的优势.
主要方法:
- 来自MSC-EV货物的转录组,蛋白组和脂组数据的分析.
- 在IBD模型中对临床前研究的审查.
- 临床前发现与现有临床试验数据的比较.
主要成果:
- 临床前研究表明,MSC-EVs通过调节促炎和抗炎介质来减少肠道炎症.
- 在IBD模型中,MSC-EVs促进粘膜的愈合,并增强肠道屏障的完整性.
- 在MSC-EVs中的特定微RNA (例如,miR-let-7a,miR-100,miR-125b,miR-20) 与IBD相关的途径有关.
结论:
- MSC-EVs作为IBD的新疗法具有显著的潜力.
- 脂质衍生MSC-EVs由于其免疫调节特性和易于隔离,特别有希望.
- 在将MSC-EV治疗转化为临床实践方面存在挑战和机遇.
更多相关视频
06:39Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
2.5K
07:45Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
Published on: September 1, 2017
12.1K
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
